Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
025000.KS Stock Summary
Top 10 Correlated ETFs
025000.KS
In the News
025000.KS Financial details
Company Rating
Strong Buy
Market Cap
210.42B
Income
64.88B
Revenue
911.12B
Book val./share
133923.77
Cash/share
37635.87
Dividend
2750
Dividend %
6.4%
Employees
345
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
4.07
Forward P/E
-
PEG
0.32
P/S
0.22
P/B
0.33
P/C
1.18
P/FCF
5.18
Quick Ratio
-
Current Ratio
2.58
Debt / Equity
0.11
LT Debt / Equity
0.01
-
-
EPS (TTM)
13.64K
EPS next Y
-
EPS next Q
-
EPS this Y
126.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
9.27%
Revenue last 5Y
3.54%
Revenue Q/Q
-0.97%
EPS Q/Q
65.39%
-
-
-
-
SMA20
-2.72%
SMA50
1.83%
SMA100
0.89%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
8%
ROC
0.09%
Gross Margin
15%
Oper. Margin
7%
Profit Margin
5%
Payout
7%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
42300.0-49200.0
52W High
-9.55%
52W Low
+5.2%
RSI
37
Rel Volume
0.78
Avg Volume
6.63K
Volume
5.14K
Perf Week
-1.22%
Perf Month
-2.73%
Perf Quarter
3.13%
Perf Half Y
2.42%
-
-
-
-
Beta
0.408
-
-
Volatility
164.44%, 705.92%
Prev Close
0%
Price
44500
Change
0.68%
025000.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 161.03K | 157.02K | 214.67K | 206.84K | 191.6K | |
Net income per share | 8.57K | 13.31K | 10.12K | 6.02K | 13.64K | |
Operating cash flow per share | 13.78K | 22.43K | 2.51K | 16.48K | 16.31K | |
Free cash flow per share | 8.85K | 18.46K | -7.65K | 5.02K | 9.8K | |
Cash per share | 15.86K | 33.95K | 38.19K | 29.49K | 37.64K | |
Book value per share | 98.08K | 110.1K | 119.12K | 122.78K | 133.92K | |
Tangible book value per share | 98.93K | 111.07K | 120.32K | 123.77K | 133.82K | |
Share holders equity per share | 98.08K | 110.1K | 119.12K | 122.78K | 133.92K | |
Interest debt per share | 2.15K | 2.84K | 19.45K | 15.59K | 15.63K | |
Market cap | 264.39B | 261.06B | 254.88B | 235.15B | 205.43B | |
Enterprise value | 270.01B | 227.93B | 289.02B | 245.55B | 191.08B | |
P/E ratio | 6.49 | 4.13 | 5.29 | 8.22 | 3.17 | |
Price to sales ratio | 0.35 | 0.35 | 0.25 | 0.24 | 0.23 | |
POCF ratio | 4.04 | 2.45 | 21.32 | 3 | 2.65 | |
PFCF ratio | 6.28 | 2.97 | -7 | 9.84 | 4.41 | |
P/B Ratio | 0.57 | 0.5 | 0.45 | 0.4 | 0.32 | |
PTB ratio | 0.57 | 0.5 | 0.45 | 0.4 | 0.32 | |
EV to sales | 0.35 | 0.31 | 0.28 | 0.25 | 0.21 | |
Enterprise value over EBITDA | 3.76 | 2.67 | 3.71 | 3.17 | 2.31 | |
EV to operating cash flow | 4.12 | 2.14 | 24.17 | 3.13 | 2.46 | |
EV to free cash flow | 6.42 | 2.6 | -7.94 | 10.28 | 4.1 | |
Earnings yield | 0.15 | 0.24 | 0.19 | 0.12 | 0.32 | |
Free cash flow yield | 0.16 | 0.34 | -0.14 | 0.1 | 0.23 | |
Debt to equity | 0.02 | 0.02 | 0.16 | 0.12 | 0.11 | |
Debt to assets | 0.02 | 0.02 | 0.12 | 0.09 | 0.08 | |
Net debt to EBITDA | 0.08 | -0.39 | 0.44 | 0.13 | -0.17 | |
Current ratio | 5.53 | 3.78 | 2.4 | 2.38 | 2.72 | |
Interest coverage | 58.36 | 119.1 | 47.87 | 20.08 | 12.23 | |
Income quality | 1.55 | 1.66 | 0.24 | 2.65 | 1.2 | |
Dividend Yield | 0.04 | 0.05 | 0.05 | 0.06 | 0.08 | |
Payout ratio | 0.25 | 0.2 | 0.29 | 0.49 | 0.24 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0.01 | 0.01 | 0 | 0.01 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.36 | -0.18 | -4.04 | -0.7 | -0.4 | |
Capex to revenue | -0.03 | -0.03 | -0.05 | -0.06 | -0.03 | |
Capex to depreciation | -1.46 | -1.13 | -2.69 | -2.53 | -1.19 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 137.53K | 181.56K | 164.72K | 128.91K | 202.76K | |
ROIC | 0.08 | 0.09 | 0.07 | 0.06 | 0.06 | |
Return on tangible assets | 0.08 | 0.1 | 0.06 | 0.04 | 0.08 | |
Graham Net | 30.04K | 39K | 33.11K | 25.9K | 34.4K | |
Working capital | 225.08B | 260.56B | 264.82B | 230.45B | 272.86B | |
Tangible asset value | 470.42B | 528.16B | 572.14B | 588.55B | 636.33B | |
Net current asset value | 212.9B | 250.86B | 254.26B | 215.4B | 255.56B | |
Invested capital | 0.02 | 0.02 | 0.16 | 0.12 | 0.11 | |
Average receivables | 60.37B | 123.43B | 141.15B | 150.37B | 141.93B | |
Average payables | 31.22B | 37.71B | 61.57B | 69.27B | 67.42B | |
Average inventory | 83.01B | 71.54B | 90.58B | 113.87B | 112.13B | |
Days sales outstanding | 57.55 | 61.65 | 55.84 | 53.65 | 55.8 | |
Days payables outstanding | 12.03 | 31.19 | 28.25 | 30.01 | 31.16 | |
Days of inventory on hand | 42.5 | 38.26 | 46.85 | 48.88 | 52.93 | |
Receivables turnover | 6.34 | 5.92 | 6.54 | 6.8 | 6.54 | |
Payables turnover | 30.35 | 11.7 | 12.92 | 12.16 | 11.71 | |
Inventory turnover | 8.59 | 9.54 | 7.79 | 7.47 | 6.9 | |
ROE | 0.09 | 0.12 | 0.08 | 0.05 | 0.1 | |
Capex per share | -4.93K | -3.97K | -10.17K | -11.45K | -6.51K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 52.33K | 48.32K | 46.47K | 48.65K | 48.17K | |
Net income per share | 660.57 | 4.78K | 2.83K | 2.27K | 3.76K | |
Operating cash flow per share | 8.4K | 2.14K | 3.34K | 7.52K | 4.83K | |
Free cash flow per share | 1.8K | -22.74 | 2.79K | 5.01K | 3.54K | |
Cash per share | 29.49K | 29.46K | 31.15K | 29.64K | 37.64K | |
Book value per share | 122.78K | 126.18K | 128.38K | 130.21K | 133.92K | |
Tangible book value per share | 123.77K | 127.31K | 128.76K | 130.36K | 133.82K | |
Share holders equity per share | 122.78K | 126.18K | 128.38K | 130.21K | 133.92K | |
Interest debt per share | 15.25K | 18.18K | 16.94K | 13.05K | 15K | |
Market cap | 235.15B | 225.64B | 223.26B | 208.52B | 205.43B | |
Enterprise value | 245.55B | 275.01B | 259.53B | 211.92B | 191.08B | |
P/E ratio | 18.71 | 2.48 | 4.14 | 4.83 | 2.88 | |
Price to sales ratio | 0.94 | 0.98 | 1.01 | 0.9 | 0.9 | |
POCF ratio | 5.88 | 22.14 | 14.07 | 5.83 | 8.95 | |
PFCF ratio | 27.53 | -2.09K | 16.85 | 8.74 | 12.2 | |
P/B Ratio | 0.4 | 0.38 | 0.37 | 0.34 | 0.32 | |
PTB ratio | 0.4 | 0.38 | 0.37 | 0.34 | 0.32 | |
EV to sales | 0.99 | 1.2 | 1.17 | 0.92 | 0.83 | |
Enterprise value over EBITDA | 15.22 | 9.8 | 7.86 | 5.66 | 8.43 | |
EV to operating cash flow | 6.14 | 26.99 | 16.36 | 5.93 | 8.32 | |
EV to free cash flow | 28.75 | -2.54K | 19.59 | 8.89 | 11.35 | |
Earnings yield | 0.01 | 0.1 | 0.06 | 0.05 | 0.09 | |
Free cash flow yield | 0.04 | 0 | 0.06 | 0.11 | 0.08 | |
Debt to equity | 0.12 | 0.14 | 0.13 | 0.1 | 0.11 | |
Debt to assets | 0.09 | 0.1 | 0.1 | 0.08 | 0.08 | |
Net debt to EBITDA | 0.65 | 1.76 | 1.1 | 0.09 | -0.63 | |
Current ratio | 2.38 | 2.1 | 2.41 | 2.58 | 2.72 | |
Interest coverage | 16.55 | 31.08 | 8.92 | 22.27 | 10.09 | |
Income quality | 11.94 | 0.45 | 1.16 | 3.22 | 1.29 | |
Dividend Yield | 0 | 0 | 0.06 | 0.01 | 0 | |
Payout ratio | 0 | 0 | 0.98 | 0.22 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.1 | 0.08 | 0.01 | |
Research and developement to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.79 | -1.01 | -0.17 | -0.33 | -0.27 | |
Capex to revenue | -0.13 | -0.04 | -0.01 | -0.05 | -0.03 | |
Capex to depreciation | -4.93 | -1.56 | -0.4 | -1.84 | -0.95 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 42.72K | 116.54K | 90.46K | 81.57K | 106.38K | |
ROIC | 0.03 | 0.03 | 0.01 | 0.02 | 0.02 | |
Return on tangible assets | 0 | 0.03 | 0.02 | 0.01 | 0.02 | |
Graham Net | 25.9K | 21.7K | 26.72K | 29.34K | 34.4K | |
Working capital | 230.45B | 222.94B | 240.24B | 246.41B | 272.86B | |
Tangible asset value | 588.55B | 605.4B | 612.28B | 619.87B | 636.33B | |
Net current asset value | 215.4B | 207.88B | 224.84B | 232.43B | 255.56B | |
Invested capital | 0.12 | 0.14 | 0.13 | 0.1 | 0.11 | |
Average receivables | -82.01B | 148.86B | 143.9B | 143.34B | 145.65B | |
Average payables | 66.17B | 77.88B | 75.17B | 64.4B | 65.66B | |
Average inventory | 128.63B | 122.52B | 130.55B | 119.03B | 110.92B | |
Days sales outstanding | 52.28 | 59.99 | 54.84 | 59.15 | 54.72 | |
Days payables outstanding | 29.37 | 40.09 | 30.38 | 30.33 | 30.77 | |
Days of inventory on hand | 47.85 | 61.29 | 61.42 | 50.96 | 52.26 | |
Receivables turnover | 1.72 | 1.5 | 1.64 | 1.52 | 1.64 | |
Payables turnover | 3.06 | 2.25 | 2.96 | 2.97 | 2.93 | |
Inventory turnover | 1.88 | 1.47 | 1.47 | 1.77 | 1.72 | |
ROE | 0.01 | 0.04 | 0.02 | 0.02 | 0.03 | |
Capex per share | -6.61K | -2.17K | -551.02 | -2.51K | -1.29K |
025000.KS Frequently Asked Questions
What is KPX Chemical Co.,Ltd. stock symbol ?
KPX Chemical Co.,Ltd. is a KR stock and trading under the symbol 025000.KS
What is KPX Chemical Co.,Ltd. stock quote today ?
KPX Chemical Co.,Ltd. stock price is $44500 today.
Is KPX Chemical Co.,Ltd. stock public?
Yes, KPX Chemical Co.,Ltd. is a publicly traded company.